title: Ciclosporin in the treatment of myasthenia gravis.
authors.affiliation: Department of Neurology, Southwestern Medical School, University of Texas Health Science Center, Dallas.
authors.forename: R S
authors.initials: RS
authors.lastname: Tindall
authors.forename: J T
authors.initials: JT
authors.lastname: Phillips
authors.forename: J A
authors.initials: JA
authors.lastname: Rollins
authors.forename: R G
authors.initials: RG
authors.lastname: Greenlee
authors.forename: L
authors.initials: L
authors.lastname: Wells
authors.forename: G
authors.initials: G
authors.lastname: Belendiuk
mesh_terms: D000328:Adult; D000368:Aged; D003524:Cyclosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy*; D011897:Random Allocation; D012307:Risk Factors
chemical_list: D003524:Cyclosporins